OTCM
PRBCF
Market cap3mUSD
Apr 27, Last price
0.15USD
Name
Precise Biometrics AB
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Precise Biometrics AB (publ) develops specialized software for reliably confirming individuals' identities across Europe, Asia, and the United States. Its product lineup includes Precise YOUNiQ, designed for digital identity verification; the BioMatch series, which comprises fingerprint algorithm solutions like BioMatch Card for secure authentication on smart cards and BioMatch Mobile for integration into smartphones and tablets; and Precise BioLive, a fingerprint software capable of detecting fake or spoofed fingerprints. The company's offerings are utilized by a wide range of clients, including sensor manufacturers, security companies, and system integrators, with applications spanning sectors such as finance, betting, healthcare, and transportation. Founded in 1997, Precise Biometrics AB (publ) is based in Lund, Sweden.
Key people
Independent Chairman of the Board · since 2018
Chief Executive Officer · since 2024
Maria Wester
Chief Financial Officer · since 2024
Chief Marketing Officer · since 2023
Sarandis Kalogeropoulos
CCO - Digital Identity · since 2023
CCO - Biometric Technologies · since 2024
Victor Kuzmin
Director · since 2025
Howard Ro
Director · since 2024
Peter Gullander
Independent Director · since 2022
Maria Ryden
Independent Director · since 2023
Independent Director · since 2020
Headquarters & legal address
Scheelevägen 27
Lund, M 223 63
SE
Lund, M 223 63
SE
Address
Scheelevagen 27
Lund, M 223 63
SE
Lund, M 223 63
SE
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||